Rivastigmine Tartrate
Overview
Rivastigmine Tartrate is an acetylcholinesterase inhibitor used for the treatment of mild to moderate dementia associated with Alzheimer's and Parkinson's disease. It works by increasing the amount of acetylcholine, a neurotransmitter involved in memory and cognition, in the brain.
API suppliers (10)
Suppliers of Rivastigmine Tartrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 9 of 10 suppliers.
8 of 10 hold a GMP certificate on record in the EU or UK registers
- ERREGIERRE SPAItaly1 active DMF GMP on record
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
- Apotex Inc.Canada1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
- JUBILANT BIOSYS LTDIndia1 active DMF
- Wuxi Fortune Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- EXCELLA GMBH GMP on record
- Emcure Pharmaceuticals LimitedIndia GMP on record
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China GMP on record
- INTERQUIM SAPeru GMP on record
Therapeutic areas
Do you supply Rivastigmine Tartrate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.